Member Info for GF123

Can’t buy any volume. Suspect it’s going over 8p again. ATB

Yes happy with that. ATB

Chelsea. Mine. ATB

For what it’s worth I thought I’d post this info.

https://reason.com/2020/04/09/preliminary-german-study-shows-a-covid-19-infection-fatality-rate-of-about-0-4-percent/

From above we can assume only 0.37% death rate for covid 19.

If we accept 15000 hospital deaths to-date, 7500 care home deaths to-date and 1000 home deaths to-date In UK we can calculate probability of current UK infections to-date.

i.e: a*(37/10000)=23500

Where a= total number of infections.

So from above a= 6351351

Current UK population is 66.5m.

So in simple terms only 9.95% of UK population have in all likelihood currently been infected by covid 19. This is of course over a probable three/four month period.

For 60% heard immunity I suspect we will need to prepare for several more months and several times the number of current deaths.

Just helps to understand world governments response to this pandemic.

However, look at 1912 Spanish flu outbreak. 2.6% death rate! Explains the many millions that died and after 1st world war too.

So it could be worse!

Let’s hope a treatment is found quickly to give time for vaccine to be developed. It all takes times and so does what SCLP are trying to achieve.

Stay safe everyone.

ATB

Innan. You are correct.

03-Feb-20 08:02:06 7.40 5,338 Buy* 6.70 7.50 395.01

There she blows the bazooka kid buy. Its taken some time but he finally managed to scrape a few hundred quid up.

ATB

The next RNS patient dosing statement?

BTW can currently sell £40k worth of shares on dummy sell. Only getting offered £750 on buy. Think we may get over and hold 8p today. Lets see.

ATB

Oh dear oh dear Crackin. Trading experts at it again I see. I agree with others Vulpes increasing their holding makes for a positive sign. ATB

If exit poll is correct democracy has spoken. Over to Sclp to now prove it’s science. ATB

Someone had some lose change. Interesting. ATB

I did indeed. All will be clear I suspect very soon!. ATB

Hi Botski. Are you going today? ATB

Says the man who didn’t shoot his bazooka when the SP was 4p, which of course now could only buy half as many shares at current SP of 8p (and rising). SK obviously isn’t happy his bazooka is 50% smaller! And isn’t good at judging buying opportunities. Yet other posters are, according to the self proclaimed astute one, hypocritical charlatans. I’m sure those reading this BB regularly will form their own views SK / the bazooka kid and his now undersized bazooka. ATB.

There is clearly some buying going on as every sell has been mopped up over several weeks. But 1 specific buyer? Unlikely. I suspect more buying will push the SP upwards prior to AGM. Lets see. What's worrying you SK? Is your unused Bazooka diminishing in size? ATB

Follow the money. ATB.

It’s a head scratcher for sure. My guess is the reason for delay may turn out to be surprising as Inanaco points out an RNS would be needed if any issues were known. So we wait patiently for confirmation? ATB.

Crumbs. Yes I agree with what you say but I guess that's my point. The combo trial should be up and running CH said it would be soon. Yet it isn't. I guess the issue may be addressed in the finals next week or maybe it wont! I just think that its a bit more complex than our BOD have lost investors confidence. There has to be a reason why BOD are not saying anything right now when clear precise statements on timescale have recently been made post fund raise. I think someone also said recently that even CH isn't responding to any emails although he has done so in the past? ATB

Anybody else finding this complete lack of news flow from company odd?

We probably all thought following vulpes fund raise that news would come regarding updates on various trials, collaborations and FDA approval etc. Yet silence!

CH has made some very clear statements in recent months, which given that milestones haven’t been met, brings into question competence of BOD. As raised last night by two BB obvious protagonists of the company.

I just feel that it’s all too simple to say BOD aren’t communicating properly and or they are incompetent. I feel there is probably a more complex issue behind where Sclp are currently.

The science seems to continue to demonstrate its robustness, subject to obvious trials currently predicted to be commencing, but data still remains elusive! Data is the driver as we all keep being told.

Who knows what bioNTech collaboration has concluded and more importantly why the UK arm of Scib1 combo Keytruda trial hasn’t yet been confirmed as started. US FDA approval aside.

My gut is there must be a very good reason for delays, again, but that’s the key question. What?

ATB

SK the Agema runner!

TF. For the record SK has a consistent agenda here to distract the BB and posts negative messages about Sclp and when people challenge him he falsely claims he is somehow being attacked / victimised. I could for example post that Agema is knowlesi but what’s the point. SK claiming inanaco and I are the same person is just another attempt to discredit other posters by him and to confuse other posters on his quite obvious agenda. He frustrates me because he makes so many false claims and if you actually read his posts over many years his disruptive style is there for all to see. Yet he demands to be taken seriously! He offers little to the bb imo but to disrupt the flow of discussion. For that he does a job. Yet I will not allow him to continue his false claims about me so I pick him up on them and highlight the ridiculousness of his posts because he is actually quite easy to ridicule. Anyone else would done the same if a poster stated rubbish about them. ATB

https://risemedia.net/2019/07/25/global-melanocyte-protein-pmel-market-2019-antigen-express-inc-immunocellular-therapeutics-ltd-immunomic-therapeutics-inc-scancell-holdings-plc-vault-pharma-inc/